Search Ontology:
ChEBI

zanamivir

Term ID
CHEBI:50663
Synonyms
  • (2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
  • 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid
  • 4-guanidino-Neu5Ac2en
  • 5-(acetylamino)-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid
  • 5-acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid
  • 5-acetamido-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid
  • GANA
  • Relenza
  • ZANAMIVIR
Definition
References
  • beilstein:7083099
  • cas:139110-80-8
  • drugbank:DB00558
  • drugcentral:2859
  • kegg.compound:C08095
  • kegg.drug:D00902
  • patent:US5360817
  • patent:WO9116320
  • pdb-ccd:ZMR
  • wikipedia.en:Zanamivir
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from zanamivir
Phenotype where environments contain zanamivir
Phenotype modified by environments containing zanamivir
Phenotype affecting zanamivir
Human Disease Model